Zynerba Pharmaceuticals
0
0
+€0.00+0% 00:00 Hari ini
Statistik
Tertinggi harian
-
Paras terendah hari ini
-
Tertinggi 52M
-
Paras terendah 52M
-
Volum
-
Vol. purata
-
Kap. pasaran
0
Nisbah P/E
-
Hasil dividen
-
Dividen
-
Pesaing
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.
Perihal
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Show more...
CEO
Mr. Armando Anido MBA
Pekerja
28
Negara
Amerika Syarikat
ISIN
US98986X1090
Penyenaraian
0 Comments
Kongsi pendapat anda
FAQ
Apakah simbol saham Zynerba Pharmaceuticals?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa Boerse Stuttgart, saham Zynerba Pharmaceuticals didagangkan di bawah simbol 6ZY.STU.
Berapa ramai pekerja yang dimiliki oleh Zynerba Pharmaceuticals?▼
Sehingga Julai 17, 2026, syarikat mempunyai 28 pekerja.
Zynerba Pharmaceuticals terletak dalam sektor apa?▼
Zynerba Pharmaceuticals beroperasi dalam sektor Lain-lain.
Bilakah Zynerba Pharmaceuticals menyiapkan split saham?▼
Zynerba Pharmaceuticals tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat Zynerba Pharmaceuticals?▼
Ibu pejabat Zynerba Pharmaceuticals terletak di Devon, Amerika Syarikat.